All Stories

  1. Identification of druggable targets from the interactome of the Androgen Receptor and Serum Response Factor pathways in prostate cancer

    Article • PLoS ONE, December 2024, PLOS

    Maria Prencipe

  2. The role of epithelial-mesenchymal transition drivers ZEB1 and ZEB2 in mediating docetaxel-resistant prostate cancer

    Article • Molecular Oncology, January 2017, Wiley

    Zoran Culig, Maria Prencipe

  3. Commercialized biomarkers: new horizons in prostate cancer diagnostics

    Article • Expert Review of Molecular Diagnostics, February 2015, Taylor & Francis

    Maria Prencipe